FDA Authorizes First COVID-19 & Flu Combination Test For Use With Home-Collected Samples

On December 4, 2020, the U.S. Food and Drug Administration (FDA) authorized the first diagnostic test for at home collection of samples to detect both COVID-19 and influenza A and B (flu). The FDA authorized Quest Diagnostics RC COVID-19 +Flu RT-PCR Test for prescription use with the Quest Diagnostics Self-Collection Kit for COVID-19 +Flu by individuals who are suspected of respiratory viral infection consistent with COVID-19 when home collection is determined to be appropriate by an individual’s healthcare provider. Under a health care provider’s order, individuals can collect a sample at . . .